GBA1 PARKINSON DISEASE

Clinical trials for GBA1 PARKINSON DISEASE explained in plain language.

Never miss a new study

Get alerted when new GBA1 PARKINSON DISEASE trials appear

Sign up with your email to follow new studies for GBA1 PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

One-Shot gene therapy tested to halt Parkinson's progression

Disease control Terminated

This early-stage trial is testing a new, one-time gene therapy called CAP-003 in adults with Parkinson's disease caused by a specific genetic change (GBA1 mutation). The main goals are to see if the treatment is safe and to look for early signs that it might help control the dise…

Matched conditions: GBA1 PARKINSON DISEASE

Phase: PHASE1, PHASE2 • Sponsor: Capsida Biotherapeutics, Inc. • Aim: Disease control

Last updated Mar 02, 2026 15:28 UTC

GBA1 PARKINSON DISEASE

Get alerted when new GBA1 PARKINSON DISEASE trials appear

One-Shot gene therapy tested to halt Parkinson's progression